chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Medication error, Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid/pertussis vaccine/ teta (INFANRIX) and was assigned a manufacturer report number concerning a 4 year old female with no concurrent conditions or past medical history who on 02Jul03 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant therapy, that same day, included a fifth dose of diphtheria toxoid/pertussis vaccine/ teta (INFANRIX) and a dose of poliovirus vaccine (IPOL). There were no other concomitant medications. On 03Jul03, twenty-four hours post vaccination, the pt developed fever and an injection site reaction characterized by redness and swelling. The pt was seen by the physician. The nurse considered the events were probably related to vaccination with Infanrix. It was noted that the diphtheria toxoid/pertussis vaccine/ teta (INFANRIX) had inadvertently been left unrefrigerated for an unspecified period of time. Addition information has been requested.
Sex: F
Vaccine: HEPAB, MMR, TTOX
Symptoms: Chest discomfort, Fatigue, Pain, Rash
Clinical narrative: Information was received from the manufacturer for hepatitis A vaccine (+) hepatitis B vaccine (TWINRIX) and has been assigned a manufacturer report number. This was originally reported by a RN concerning a female with a sensitivity to yeast who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) on an unspecified date. Concomitant therapy on the same day included a second dose of hepatitis A vaccine (+) hepatitis B vaccine (TWINRIX) into the right deltoid and a dose of tetanus toxoid. On the same date, at an unspecified time post immunization the pt developed chest tightness, aches all over her body and fatigue. Additionally, she developed a rash on the arm where the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) was injected. It was noted that the pt had no adverse experiences following the receipt of the first injection of TWINRIX. The events resolved after seven days. Additional information has been requested.
Age: 1.08
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash maculo-papular, Stomatitis
Clinical narrative: Information has been received from a physician concerning a 13 month old Asian female with protein C deficiency who on 24Jul03 (also reported as 28Sep03) AT 13:30 was vaccinated in the right arm with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant therapy included enoxaparin sodium (LOVENOX) being given for protein C deficiency. The day after vaccination, on 25Jul03, the pt developed a fever of 103F, which continued for 3 to 4 days. The pt also developed a generalized maculopapular rash, which started on her head and face and progressed down, including the oral mucosa. The pt was seen by the physician on 28Jul03 and still had the rash. The pt was prescribed calamine lotion and diphenhydramine hydrochloride (Benadryl) PO. It was noted that the pt's mother is a physician's assistant and was going to decide if a follow up visit was needed. Follow up information indicated that no diagnostic or laboratory studies were performed. The pt's outcome was reported as unknown. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Anxiety, Convulsion, Loss of consciousness
Clinical narrative: Information has been received from a physician concerning a female pt who was vaccinated with a second dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). The mother reported that the pt experienced a seizure (possibly anxiety attack/passed out) following the vaccination. It was noted that she did not received the vaccine at this practice because the pt was new to the practice. The doctor had not seen the pt as of yet and therefore does not have a chart. It was unknown if medical attention was sought. Further information has been requested. Upon internal review, seizures are considered to be an important medical event. It was noted that the pt's brother had a similar experience following the administration of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) . Other Medical Event (OMIC).
Age: 4.0
Sex: M
Vaccine: DPP, HIBV, MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician via a company representative concerning a 4 year old white male pt who on 30Aug00 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant vaccinations on 30Aug00 included a fourth dose of Hib conj vaccine and a fourth dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid into the left thigh. The physician drew a titer for MMR (reported as an MMR Immunity Profile) and it came back on 29Jul03 that this pt had no immunity against mumps (no seroconversion). It was noted that the pt had no adverse events following prior vaccinations. No other information was available. Additional information has been requested.
Age: 29.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a nurse concerning a 29 year old female pt who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). On 12Jun2003 had a measles titer performed and the result was borderline for measles. The nurse did not have the pt's early childhood immunization records to see if she received measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in the past. Additional information was not available at this time. In follow up information the nurse reported that the pt had no adverse reaction from the vaccine. The pt was immunized with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) as a baby. It was noted that the pt just didn't have immunity. No further information was available according to the reporter. Unspecified medical attention was sought.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Ocular hyperaemia, Rash
Clinical narrative: Information has been received from a mother concerning her 4 year old son who on 29Jul03 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). On 01Aug03 the pt developed a rash and red eyes. The rash spread throughout the pt's entire body. The pt's mother brought him to the hospital and the nurse stated it was viral exanthem. The pt had shown signs of improvement. The reporter had no other intention of seeking medical treatment. It was reported that the pt had not recovered. Additional information has been requested.
Age: 51.0
Sex: F
Vaccine: MMR
Symptoms: Hypoaesthesia, Oedema peripheral, Pain
Clinical narrative: Information has been received from a RN concerning a 51 year old female phlebotomist with a low rubella titer, reoccurring achy joints and a pollen allergy and a history of lyme disease and thyroid surgery (1980) who on 17Jul03 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant therapy included levothyroxine Na (Synthroid) and fexofenadine hydrochloride (+) pseudosphedrine hydrochloride (ALLEGRA-D). A few days post vaccination, the pt developed pain in both hands. During the week of 28Jul03, the pt notified the reporter, the employee health nurse, of the symptoms including numbness with occasional swelling of both hands. Unspecified medical attention was sought. On 05Aug03, the pt was seen and the symptoms continued. It was reported that the pt had no history of arthritis of hands but she was a phlebotomist at the hospital and a part time manicurist. The pt did not know if she was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in the past. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a young female with an egg allergy who was vaccinated SC with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Subsequently the pt developed a rash all over her body. Unspecified medical attention was sought. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a RN concerning a female employee who was vaccinated with two or more doses of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Subsequently the pt had a negative measles titer. It was noted that the pt was not pregnant. Medical attention was sought. No additional information was provided. It was also noted that the same source reported another pt who had an equivocal measles titer follow two or more doses of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). No further information is available. The physician may not be contacted.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash maculo-papular
Clinical narrative: Information has been received from a person at a physician's office and a physician concerning an 18 year old female who was vaccinated at the age of 15 months on 06May1986 with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). A day or two later, the pt developed a measles like rash and fever. Medical attention was sought but no treatment was needed. The condition resolved and the pt recovered. A second dose of the vaccine was not administered. The physician noted that the pt's mother informed him of the reaction, but that he never saw the pt for the reaction. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: DPP, IPV, MMR
Symptoms: Rash
Clinical narrative: Information has been received from a RN concerning a 5 year old female who on 06Aug2003 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant therapy on 06Aug03 included a dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (DTAP) and a dose of poliovirus vaccine  (IPOL). On 08Aug03, it was noted that the child presented with rash again. There was no prescription drug required for treatment. The child has not been seen by a physician for this condition. There was no product quality complaint involved. The reporter also mentioned that on 27Jan1999 at 12 months old the child had received a dose of varicella virus vaccine live and developed a rash around the site of injection described as "bumpy varicella-like" that was confined in a 2x2 inch area on the child's thigh. It was noted that every year around the anniversary of her original immunization, the child developed a rash in the same confined area of her thigh as when she was a baby. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a RN concerning a female employee who was vaccinated with two or more doses of MMRII. Subsequently the pt had an equivocal measles titer.  It was noted that the pt was not pregnant.  Medical attention was sought. No additional information was provided.  It was also noted that the same source reported another employee with a negative measles titer following vaccination with two or more doses of MMRII (WAES 0308USA01010).  No further information is available. The physician may not be contacted.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a consumer concerning a 12 month old male pt with no medical history who on approximately 05/11/03 was vaccinated SC with a 0.5mL dose of MMRII. Concomitant therapy on approximately 05/11/03 included a dose of varicella virus vaccine live. Ten days later, on approximately 05/21/03 the pt developed a rash (# of lesions not known) all over the body. Subsequently, the pt recovered on his own in one week. It was noted that the pt's twin sister had the same experience (WAES # 0308USA01722).  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Pain
Clinical narrative: Information has been received from a male who is a pharmacist who on 07/09/03 was vaccinated with a dose of MMRII.  Subsequently the pt experienced testicular pain. The pt is awaiting results of an ultrasound. He was not hospitalized. According to the pt he is not experiencing pain.  No additional information was provided.  Unspecified medical attention was sought. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a consumer concerning a 12 month old female pt with no medical history who on approximately 05/11/03 was vaccinated SC with a 0.5mL dose of MMRII. Concomitant therapy on approximately 05/11/03 included a dose of Varicella virus vaccine live. Ten days later, on approximately 05/21/03 the pt developed a rash (# of lesions not known) all over the body. Subsequently, the pt recovered on her own in one week. It was noted that the pt's twin brother had the same experience (WAES # 0308USA01318).  Additional information has been requested.
Age: 33.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a nurse practitioner concerning a 33 year old female pt who 3 years ago in approximately 2000, prior to her pregnancy, was vaccinated IM with a booster dose of MMRII. The pt was vaccinated with a dose of MMRII as a child. It was reported that recently her rubella titer came back negative. No additional information was available. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a NP concerning a 35 year old female employee who on 06/23/03 & 08/06/03 was vaccinated with a dose of MMRII. Subsequently the pt had a equivocal measles titer. Medical attention was sought. The pt was not pregnant. No additional information was provided and the physician may not be contacted.  Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a RN concerning a 12 month old male with no known allergies who on 02/15/99 was vaccinated IM with a first dose of MMRII. There was no concomitant medication. On 03/01/99, two weeks following vaccination, the pt developed a rash all over his body which lasted for one week. The pt took Benadryl and the rash "disappeared". It was noted that the pt sought medical attention. No additional information was available at the time of the report. No additional information is expected.
Age: 20.0
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a RN concerning a female "in her twenties", with a sulfa allergy, who was vaccinated SC on an unspecified date with a 0.5mL dose of MMRII (Lot # not reported). About two weeks post-vaccination the pt developed a rash all over her body. The pt did not seek medical attention. The pt's outcome was reported as not recovered. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: DTP, IPV, MMR
Symptoms: Eyelid oedema, Nasal congestion, Oedema, Pyrexia, Tonsillitis
Clinical narrative: Initial and follow up information has been received from a physician and follow up information from a receptionist at the physician's office concerning a 4 year old male pt who per the physician was well at the time of vaccination, with no pertinent medical history and no allergies. On 08/22/03 the pt was vaccinated SC with a second dose, 0.5mL, of MMRII (Lot # 645405/0132N).  Concomitant therapy included vaccination in different arms on 08/22/03 with DTP and IPV. On 08/26/03 the pt presented to the MD's office with mild fever, congested nose and swollen eye lids. The parents treated the child with Tylenol. On 08/28/03 the pt presented again with fever of 103, nasal congestion, swollen tonsils with exudate, not sleeping well (also reported as difficulty sleeping) due to the congestion and slightly swollen eye lids. On follow up the physician reported that the child had been diagnosed with tonsillitis and had been treated with amoxicillin. The physician reported that "she thinks that the child is better because she has not heard back from the father of the child as of yet".  It was also reported by a receptionist at the office that "the child has recovered because she has not come back to the office again." The physician reported that she did not think that the reaction had anything to do with the MMRII.  Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR
Symptoms: Injection site rash
Clinical narrative: Information has been received from a physician and a nurse concerning a 15 month old female pt with no "pertinent medical history and no allergies" who on 08/18/03 was vaccinated SC in the right thigh with a 0.5mL dose of MMRII (Lot # 643955/1083M).  On 08/28/03 the pt presented to the MD's office with a rash at the injection site. The nurse reported that no treatment was required. Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: DTP, IPV, MMR, VARCEL
Symptoms: Drug administration error
Clinical narrative: Information has been received from a physician concerning an 8 year old female pt who on 08/27/03 was vaccinated with a second dose of MMRII. It was reported that the pt wiggled and some of the vaccine went into her "subdermal space" rather than the SC area of her left arm. Concomitant therapy included a dose of varicella virus vaccine live, DTP (manufacturer unknown) and IPV (manufacturer unknown). It was reported that "prior" to the MMRII vaccination, the pt received tuberculin purified protein derivative (manufacturer unknown) (A TB test) and became very frightened. No further information was provided. Unspecified medical attention was sought. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Cough, Pharyngolaryngeal pain, Pyrexia
Clinical narrative: Initial and follow up information has been received from a father concerning his 5 year old daughter with a history of ear infection NOS who on 08/29/03 was vaccinated with MMRII, strength of 0.5mL, via SC injection at 2:30PM. The reporter stated that the pt awoke on 08/30/03 with cold like symptoms such as "cough, sore throat, and low grade fever". The pt was treated with Tylenol Cold Multi-Symptom, Ibuprofen and cough patches. The pt's symptoms have worsened. The pt's father did not seek medical attention for his daughter "but will do so".  Follow up information revealed that the pt's father called the pediatrician and he spoke with the NP. The NP did not prescribe any treatment. The cold like symptoms resolved and the cough lasted for one week and then it resolved. The pt did not require a visit to the physician. Additional information is not expected.
Sex: M
Vaccine: MMR
Symptoms: Injection site oedema, Pyrexia, Rash
Clinical narrative: Information has been received from a RN concerning a male child who was vaccinated in approximately 07/03 SC with a 0.5mL dose of MMRII (Lot # 645518/0181N).  It was reported on 08/27/03, the within the last month, there had been an increase in adverse events following vaccination with MMRII. The pt developed a bad rash all over his body, fever and injection site swelling of the leg. The child went to the ER, but treatment given was unknown. The pt was not hospitalized. Subsequently, the pt recovered. It was unknown if concomitant medication was taken. The pt's past medical history was unknown. It was unknown if diagnostic tests were performed. The same reporter also noted that 9 other children developed rashes, fever and injection site swelling of leg following vaccination with MMRII (WAES # 0308USA02721).  The reporter expressed a concern regarding the lot number. The records of testing prior to release of this lot have been checked by quality assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Anaphylactic reaction, Medication error
Clinical narrative: Information has been received from a pharmacist concerning a currently 4 year old male child who was vaccinated on unspecified dates with a first and second dose of MMR (lot # not reported). Subsequently, the patient experienced a rash after the first dose and an anaphylactic reaction after the second dose of MMR. After the second dose the patient was taken to the hospital for treatment. The mother was told that the reaction was probably from an egg allergy. The pharmacist did not know if the child was admitted or treated and released from the hospital. Upon internal review, anaphylactic reaction was determined to be an other important medical event (OMIC). Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a RN concerning a 4 year old female who on 08/17/92 was vaccinated with a first dose of MMRII (Lot # 603397/0260V).  Subsequently the pt experienced a "severe reaction".  Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: MMR
Symptoms: Viral infection
Clinical narrative: Information has been received from a RN concerning an 11 year old male who was vaccinated "on the usual schedule" with a first and second dose of MMRII. On approximately 09/06/03 the pt was seen in the physician's office with what appeared to be mumps. It was noted that the pt had a possible exposure one week ago. A titer was obtained on 09/06/03, but results were not available as of this report. It was unknown if treatment was required. Follow up information was received on 10/28/03 in which a RN reported that it was determined that the adverse event filed was not due to the MMRII vaccine, but due to a virus. Additional information is not expected.
Sex: M
Vaccine: MMR
Symptoms: Convulsion, Pyrexia
Clinical narrative: Information has been received from a mother concerning her son with no allergies or past medical history who was vaccinated SC with a 0.5ml dose of MMR. There was no concomitant medication. Two or three days after the vaccination the patient got a fever, then he had seizure and was brought to the pediatric office and no laboratory testing done. The patient's mother does not remember exactly when he go the vaccination. The mother felt that the patient's experiences were disabling at that time. It was reported that the patient recovered. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Visual field defect
Clinical narrative: Information has been received from a LPN concerning a 25 year old female with autoimmune hepatitis who on 09/11/03, was vaccinated with MMRII, SC. Concomitant therapy included six-mercaptopurine for her autoimmune hepatitis. On 09/12/03, the pt experienced peripheral vision abnormalities. The outcome of the peripheral vision abnormalities was not reported. It was unknown whether vaccination with MMRII was related to peripheral vision abnormalities. Unspecified medical attention was sought. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a RN concerning an adult male pt who on 09/03/03 received a "primary vaccination" with a dose of MMRII (Lot # 644581/1082M).  Two weeks post vaccination the pt developed a rash and slight fever. Unspecified medical attention was sought.  The RN also reported that an adult female pt experienced rash and slight fever following vaccination with a dose of MMRII (WAES # 0309USA01817).  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Injection site reaction
Clinical narrative: Information has been received from a pharmacist concerning a male pediatric patient with unknown medical history and allergies who was vaccinated one time with a dose of MMR vaccine live (lot # unknown). The reporter indicated that the patient had a reaction to the vaccine. No further information was available. Unspecified medical attention was sought. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Malaise
Clinical narrative: Information has been received from a 39 year old female patient, with no pertinent medical history or diagnostic studies, who in 1990 at the age of 25, when she was in graduate school, was vaccinated with a dose of MMR vaccine live (lot # not available). There was no concomitant medication. The patient experienced sickness and was not feeling well for about two weeks. She passed out once during this time. She did not see a doctor and she recovered "back to normal" after two weeks. In follow up information from the patient it was noted that the medical records from the student health center had been destroyed, therefore no further information is available.
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a registered nurse concerning an adult female patient who on 03-Sep-2003 received a "primary vaccination" with a dose of MMR vaccine live (Lot #645265/0097N). Two weeks post vaccination the patient developed a rash and slight fever. Unspecified medical attention was sought. The registered nurse also reported that an adult male patient experienced rash and slight fever following vaccination with a dose of MMR vaccine live (WAES 0309USA01604). Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAP, HIBV, IPV, MMR
Symptoms: Erythema, Rash maculo-papular
Clinical narrative: Information has been received from a registered nurse concerning a 4-year-old white female with no allergies or medical history who on 27-Jan-2003 between 13:00 and 14:00 was vaccinated with a first SC in the right thigh with MMR vaccine live (lot 641628/063M). Concomitant therapy at the same time included a third dose IM in the left thigh of diphtheria toxoid (+) pertussis acellular vaccine (+) tetanus toxoid (Tripedia) (HDTPA575A2), a third dose IM in the left thigh of inactivated poliovirus vaccine (IPOL) (HW0334-2) and a third dose IM in the right thigh of HIB conj vaccine (tet toxoid) (ACTHIB) (HUA715AA). There was no illness at the time of vaccination and no other concomitant medications. It was reported that, in February 2003, between 09:00 and 10:00, the child developed red dots over her entire body. This was 1.5 to 2 weeks after receiving the vaccines. The red dots started on the legs then moved to her stomach. Symptoms lasted one week and the patient recovered. There were no labs or diagnostic tests performed. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information has been received from a pharmacist concerning a currently 5 year old female patient who about 3 1/2 years ago was vaccinated with a dose of MMR vaccine live (lot # not available). One day after vaccination the patient developed hives all over her body. Unspecified medical attention was sought. Subsequently, the patient recovered. No further information is available.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received on 18-Sep-2003 from a registered nurse concerning an approximately 21 year old female who at 15 months of age and at 9 years of age was vaccinated with MMR vaccine live. In early September 2003 at a visit, the patient had a negative titer for measles. The reporter considered the event as vaccine failure. Subsequently, the patient was revaccinated at that visit. The patient reportedly had no untoward effects." Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Infection, Rash
Clinical narrative: Information has been received from a health professional concerning a 4-5 year old female patient who on 03-Sep-2003 was vaccinated with a dose of MMR vaccine live. On 07-Sep-2003, four days after vaccination, the patient developed a measles rash all over her body which lasted three to four days. It was noted that the patient recovered. Unspecified medical attention was sought. Additional information has been requested.
Age: 29.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician concerning a currently 32 year old female patient who as a child had received a primary series of MMR vaccine live (lot # not reported) and subsequently had a negative titer. Unspecified medical attention was sought. No further information is available. It was also reported that the patient had received 3 booster doses of rubella virus vaccine live and the patient's antibody titer was still negative (WAES #0309USA1993).  This is in follow-up to report (s) previously submitted on 11/26/2003. Information has been received from a physician concerning a 31 year old female patient with a history of 2 miscarriages who in 2001 was vaccinated with a booster dose of rubella virus vaccine live (Wistar RA 27/3) (lot# not available) . It was reported that the patient had received  2 other booster doses of rubella from different doctors in 1999 and 2001 and the patient had been given a primary series of "MMR" as a child. The physician reported on 16-SEP-2003 that he had just done an antibody titer and it was still negative. Laboratory evaluation revealed a rubella antibody titer was negative. The physician reported he planned to order another antibody titer. No further information is available. It was reported that the patient had a negative titer following vaccination with MMR II (WAES# 0309USA02392).
Age: 33.0
Sex: F
Vaccine: MMR
Symptoms: Musculoskeletal stiffness
Clinical narrative: Information has been received from a mother concerning her 33 year old daughter who on 05-Sep-2003 was vaccinated with a dose of MMR vaccine live (lot # not provided). Subsequently, the patient experienced muscle stiffness in her hip area. The stiffness had not gone away. Th patient had been taking naproxen sodium (Aleve) to help treat symptoms. No additional information was provided.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Rash
Clinical narrative: Information has been received from a health department nurse via a company representative concerning a 35-40 year old female patient, who came from a foreign country on 10-Jan-2003, who has a history of negative rubella titer, who on 11-Aug-2003 was vaccinated with a dose of MMR virus vaccine live. It was noted that the patient was vaccinated after giving birth on 11-Aug-2003. On 23-Aug-2003 a general rash developed. A rubella titer was done on 23-Aug-2003 and it was reported that her "ITM' and "ITT" were both negative. On 28-Aug-2003 the rash was gone. On 11-Sep-2003, the patient tested positive for rubella. Unspecified medical attention was sought. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, PNC
Symptoms: Pruritus, Rash maculo-papular
Clinical narrative: Information has been received from a health professional concerning a 1 year old Caucasian male with no past medical history or allergies, who on 16-Jun-2003 was vaccinated in the left thigh with a first dose of MMR virus vaccine live (lot #640788/1180M). Concomitant therapy, that same day, included a second dose pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (Crm197) (Prevnar) (lot #491576) given in the left thigh. There was no illness at the time of vaccination. Subsequently, on an unspecified date, the patient developed "5 spots various spots on face and diaper area." and itching. The patient was treated with calamine lotion for itch. In 2-3 weeks the patient recovered. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a receptionist at a physician's office concerning a 11 year old female, who at the age of 12 months was vaccinated with a dose of MMR vaccine live (lot unknown). The morning following vaccination, the patient had a rash. Medical attention was sought. It was unknown if any treatment was required. It was unknown if the patient was on any concomitant medications or if any labs were performed. The patient's past medical history was unknown. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a doctor of pharmacy concerning a 26 year old female hospital employee who in 2001 was vaccinated with a dose of MMR virus vaccine live (lot number not available). It was reported that the patient received the vaccination 2 years ago, and subsequently had a negative measles titer (date not reported). Unspecified medical attention was sought. Additional information has been requested.
Age: 23.0
Sex: M
Vaccine: MMR
Symptoms: Arthralgia, Myalgia, Pain, Pyrexia
Clinical narrative: Information has been received from a nurse practitioner concerning a 23 year old male patient, with no pertinent medical history and no drug allergies, who is a foreign exchange student who on 27-Aug-2003 was vaccinated SC into the right arm with a dose of MMR virus vaccine live (lot #643497/0770M). Number of previous dose unknown but it was reported that the patient "had disease." There was no concomitant medication. On 13-Sep-2003 the patient developed myalgia, polyarthralgia, pain in lower extremities (anterior bilateral calves and thighs); tender in knees and ankles and low grade fever of 99.3. There was no discomfort in the upper extremities and no rash or joint effusions were reported. Anti-inflammatory (ibuprofen) and rest was recommended for treatment. There were no diagnostic tests or laboratory findings. It was reported that there was no illness at the time of vaccination. Subsequently, the patient recovered spontaneously from his experiences on 27-Sep-2003. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: FLUX, MMR
Symptoms: Rhinorrhoea, Sinus congestion
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male patient with an egg allergy who was vaccinated with a dose of MMR (lot # unavailable) by another health care provider. According to the patient's mother, the patient developed a runny nose and sinus congestion that lasted 3 months after he was vaccinated. Follow up information was received from a registered nurse. It was noted that the patient was also vaccinated with a dose of influenza virus vaccine (unspecified) (manufacturer unknown). According to the reporter, the patient's mother stated that the patient had "symptoms persisting for months after receiving a flu and MMR injection" a the pediatrician's office. It was reported that the patient had recovered. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: HBHEPB, MMR, PNC, VARCEL
Symptoms: Cough, Injection site reaction, Pyrexia, Rash, Rhinorrhoea
Clinical narrative: Information has been received from a licensed practical nurse concerning a 12 month old Hispanic male patient (previously reported as female), with a cough and runny nose and no previous medical history, who on 05-Nov-2003 (previously reported as 16-Sep-2003) was vaccinated SC into the left thigh with a first dose of MMR virus vaccine live (lot #645902/0509N). Concomitant vaccination on 05-Nov-2003 included a first dose of varicella virus vaccine live (lot #646361/0572N) SC into the right thigh, a third dose pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) IM into the left thigh (lot #494-303) and a third dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (lot #643888/753M) IM into the right thigh. On 18-Nov-2003, the patient developed a rash and a body temperature measurement of 98.6 degrees Fahrenheit (axillary) for three days. It was reported that the patient was diagnosed with an "MMR vaccine reaction". It was reported that the patient recovered from his experiences. There was no relevant laboratory or diagnostic tests done. No further information was expected.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a nurse practitioner concerning a female, 24 years old at the time of this report, who was vaccinated as a child with a 0.5 ml dose (SC) of MMR virus vaccine live (lot # not reported). Subsequently the patient showed no immunity to rubeola. The patient received a "booster dose" in 1997 and in August 2001. A titer drawn in October 2003 was still negative for rubeola. The patient refused to receive another dose of MMR virus vaccine live and stated that she does no seroconvert. Unspecified medical attention was sought. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Infection, Pyrexia, Rash, Rash maculo-papular
Clinical narrative: Information has been received from a health professional concerning a 4 year old male with no past medical history who on 26-Sep-2003 was vaccinated with SC 0.5 ml dose of MMR virus vaccine live (lot #644843/1229M). There was no concomitant medication. On 03-Oct-2003 the patient presented to the office with a classic measles rash on the trunk, face and neck. He had a low grade diffuse fever and Koplik's spots. No laboratory of diagnostic testing was done. Additional information has been requested.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Lymphadenopathy, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 30 year old female patient who on 22-Sep-2003 was vaccinated subcutaneously in the left arm with a dose of MMR virus vaccine live (Lot #635145/0030N). In approximately October 2003, the patient developed a rash on her chest and back and swollen lymph glands including lymphadenopathy of her neck and head, but no fever. The patient visited her doctor, who stated this was caused by the rubella vaccine. Blood work was taken and the results were pending. At the time of the report, the patient was feeling better and it was noted that the adverse experience abated. At the time of the report, the patient "still had the rash on her jaw, but the other symptoms had subsided." The reporter also noted that the outcome was "recovering with sequalea". A product quality complaint was not involved. Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician concerning a 15 month old male who on 19-Sep-2003 was vaccinated with a dose of MMR virus vaccine live. It was unknown if the patient was on concomitant therapy. The patient's medical history was also unknown. On 22-Sep-2003 the patient developed hives. Medical attention was sought and the patient was treated with diphenhydramine hydrochloride (Benadryl). It was unknown if lab tests were performed. The hives lasted for 3 days. Subsequently, the patient recovered.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning her friend, an adult female patient, who was vaccinated as a child with her dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. Subsequently, the patient developed measles as an adult. Unspecified medical attention was sought. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from an office manager, also reported as a healthcare worker, concerning a currently 4 year old female patient who was vaccinated with her first dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live before 12 months of age. Therefore, as second dose was given at 20 months of age. On 13OCT2003 it was reported that one month ago the patient was vaccinated with a third dose of measles virus vaccine live + mumps vaccine live + rubella virus vaccine live. Concomitant therapy included vaccination with several other vaccines, not specified, on the same day as vaccination with the third dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live . within 24 hours of the third dose of vaccination the patient developed a rash. Unspecified medical attention was sought. Additional information has been requested.
Sex: U
Vaccine: DTP, IPV, MMR
Symptoms: Contusion, Rash macular
Clinical narrative: Information has been received from a registered nurse concerning a patient with an unknown medical history who was vaccinated with measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. Concomitant therapy on the same day included a dose of poliovirus vaccine inactivated and a dose of diphtheria toxoid + pertussis vaccine + tetanus toxoid. Subsequently, 2 days after the vaccination, the pt developed blotch bruising on hands and legs. The reporter indicated a possibility of child abuse. It was noted that the patient had not recovered at the time of the report. No further information was provided. Unspecified medical attention was sought. Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: FLUX, MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a pharmacist concerning his 15 month old son with no prior medical history or allergies who on 10OCT2003 was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. Concomitant vaccination received on 10OCT2003 included varicella virus vaccine live and influenza virus vaccine. There was no other concomitant medication. On 18OCT2003 the patient developed a rash of small red dots on his back and stomach and a slight fever. The next day, the rash was on his head but the other area were starting to fade, he was afebrile and napping longer than usual. Medical attention was sought and he was treated with Tylenol as needed. Additional information was requested.
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Pyrexia, Urticaria, Viral infection
Clinical narrative: Information has been received from a mother concerning her son with a history of coeliac disease who in March 1997, was vaccinated SC with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. Ten days after the vaccination the patient's physician said the patient experienced measles. The patient broke out in red and swollen hives all over his body. The patient had a fever of 105 degrees Fahrenheit and the face of the patient swelled. The patient was taken to the emergency room and was given a shot of diphenhydramine hydrochloride. The patient was not admitted to the hospital and he recovered completed within 4 weeks. Upon internal review, fever of 105 degrees was considered to be an important medical event. Additional information has been requested (OMIC)
Sex: F
Vaccine: MMR
Symptoms: Injection site haemorrhage, Injection site pain, Injection site rash
Clinical narrative: Information has been received from a pharmacist concerning a female patient, who is a medical assistant, who on 07JUL2003, also reported as 21OCT2003, was "accidentally" vaccinated IM (into the left deltoid) instead of subcutaneously with a 0.5 ml dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. There was no concomitant medication. The patient developed a rash at the injection site. It was noted that the patient reported some copious bleeding and localized pain at the injection site. Medical attention was sought. There were no labs performed and no prescription drug required. A MMR titer was planned to be drawn. The patient's medical history was unknown. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Speech disorder
Clinical narrative: Information has been received from a consumer concerning her daughter, a twin, who was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. The reporter indicated that the patient's speech is not clear and she takes speech class. It was noted that the patient was not tested by a neurologist. A product quality complaint was not involved. Additional information has been requested. The reporter also indicated that the patient's twin brother experienced an adverse event after therapy with measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live.
Age: 40.0
Sex: U
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician who was told by another physician that a 40 year old patient was vaccinated with two doses of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. It was reported that the patient "did not respond" after a month to the two doses of measles virus vaccine live + mumps vaccine live + rubella virus vaccine live. No further information available at this time. Unspecified medical attention was sought. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: DT, FLUX, MMR, TYP
Symptoms: Rash
Clinical narrative: Information has been received from a nurse practitioner concerning a 23 year old female with no prior medical history and no allergies who on 07OCT2003 was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. Concomitant vaccination on 07OCT2003 included a dose of influenza virus vaccine and diphtheria toxoid + tetanus toxoid + typhoid vaccine inactivated. There was no other concomitant medication. On 21OCT2003, two weeks later, the patient developed a rash with small red bumps, no itching, and was afebrile. The patient's rash persisted. Medical attention was sought and no treatment was required. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Diarrhoea, Pyrexia
Clinical narrative: Information has been received from a physician and a medical assistant concerning her 1.25 month old daughter who on 10OCT2003 was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live, and concomitant suspect therapy varicella virus vaccine live. On 16OCT2003 the patient was vaccinated with a second dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live, and concomitant suspect therapy varicella virus vaccine live. In follow up, the physician reported that the patient was "behind in her immunizations. In the process she was given a second dose of Varicella and MMR one week after the first one. On 22OCT2003, six days after the second vaccinations, the patient developed a fever, which ranged from 100 to 104 degrees and diarrhea. The patient sought medical attention, and was prescribed antibiotics b her physician. The patient's fever was treated with acetaminophen and ibuprofen. In follow up, on 28OCT2003 a complete blood cell count was performed on the patient, which revealed a white blood cell count of 11x10E3. The patient's mother reported that the patient had not started therapy with antibiotics due to the normal white blood cell count. The patient's fever and diarrhea persisted. Additional information is not expected.